SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001171520-18-000071
Filing Date
2018-02-09
Accepted
2018-02-09 14:30:32
Documents
1
Group Members
HABIB KAIROUZJOSHUA RUCHKARIBA LLCMARK LESCHLYPINNACLE INVESTMENT PARTNERS Q-6, L.P.PINNACLE MANAGEMENT PARTNERS LLCRHO CAPITAL PARTNERS LLCRHO VENTURES V AFFILIATES, L.L.C.RHO VENTURES V, L.P.RMV V, L.L.C.RUGU PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 eps7749.htm SC 13G 188229
  Complete submission text file 0001171520-18-000071.txt   190274
Mailing Address C/O RHO CAPITAL PARTNERS, INC. 152 WEST 57TH STREET, 23RD FLOOR NEW YORK NY 10019
Business Address C/O RHO CAPITAL PARTNERS, INC. 152 WEST 57TH STREET, 23RD FLOOR NEW YORK NY 10019 212-751-6677
Rho Ventures V, L.P. (Filed by) CIK: 0001325383 (see all company filings)

IRS No.: 201953730 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Subject) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90033 | Film No.: 18590882
SIC: 2834 Pharmaceutical Preparations